Lv7
3290 积分 2023-10-10 加入
Tucatinib in Combination With Trastuzumab Deruxtecan in Patients With Previously Treated HER2+ Unresectable Locally Advanced or Metastatic Breast Cancer: An Open-Label Phase 2 Study
12天前
已完结
Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial
12天前
已完结
Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial
5个月前
已完结
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
5个月前
已完结
The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Single-Arm Phase II Clinical Trial
10个月前
已完结
A Phase Ii, Single-Arm Trial Of Neoadjuvant Axitinib Plus Avelumab In Patients With Localized Renal Cell Carcinoma Who Are At High Risk Of Relapse After Nephrectomy (Neoavax)
11个月前
已完结
Concurrent Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer
1年前
已完结
Clinical importance of the expression of CD4+CD8+ T cells in renal cell carcinoma
1年前
已完结
First-Line Therapy For Advanced Non-Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
1年前
已完结
Re: First-line Therapy for Advanced Non–Clear Cell Renal Cell Carcinoma. A Systematic Review and Meta-analysis
1年前
已关闭
皖公网安备34019202002308
